CZ
Vypnout grafiku Tisk stránky
  • Změnit
    velikost písma

Významné zahraniční publikace 2010-2015

2015

Living-donor kidney transplantation for atypical haemolytic uremic syndrome with pre-emptive eculizumab use. 
Parikova A, Fronek J, Viklicky O. Transpl Int. 2015 Mar;28(3):366-9.

Circulating biomarkers of tolerance. 
Girmanova E, Hruba P, Viklicky O. Transplant Rev (Orlando). 2015 Apr;29(2):68-72.

New strategies for evaluating the quality of kidney grafts from elderly donors. 
Wohlfahrtova M, Viklicky O Transplant Rev (Orlando). 2015 Oct;29(4):212-8.

Molecular patterns of subclinical and clinical rejection of kidney allograft: quantity matters. 
Wohlfahrtova M, Tycova I, Honsova E, Lodererova A, Viklicky O. Kidney Blood Press Res. 2015;40(3):244-57.

Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changes. 
Hrubá P, Brabcová I, Gueler F, Krejčík Z, Stránecký V, Svobodová E, Malušková J, Gwinner W, Honsová E, Lodererová A, Oberbauer R, Zachoval R, Viklický O. Kidney Int. 2015 Oct;88(4):785-95.

Effect of induction therapy on the expression of molecular markers associated with rejection and tolerance. 
Krepsova E, Tycova I, Sekerkova A, Wohlfahrt P, Hruba P, Striz I, Sawitzki B, Viklicky O. BMC Nephrol. 2015 Aug 19;16:146.


2014

Tubular atrophy and low netrin-1 gene expression are associated with delayed kidney allograft function.
Wohlfahrtová, M., Brabcová, I., Železný, F., Baláž, P., Janoušek, L., Honsová, E., Lodererová, A., Wohlfahrt, P., Viklický, O. Transplantation. 2014, 97(2), 176-183.

Recent trials in immunosuppression and their consequences for current therapy. 
 Wohlfahrtová, M., Viklický, O. Current Opinion in Organ Transplantation. 2014, 19(4), 387-394.

Early exercise training after renal transplantation and asymmetric dimethylarginine: the effect of obesity. 
Teplan, V., Mahrová, A., Piťha, J., Racek, J., Gürlich, R., Teplan, V. Jr., Valkovsky, I., Štollová, M. Kidney and Blood Pressure Research. 2014, 39(4), 289-298.

Asymmetric dimethylarginine and endothelial progenitor cells after renal transplantation: the effect of exercise training.
Teplan, V., Králová Lesná, I., Piťha, J., Mahrová, A., Racek, J., Valkovský, I., Sekerková, A., Štollová, M. Physiological research. 2014, 63(suppl. 3), S411-S417.

The relationship between estimated GFR based on the CKD-EPI formula and renal inulin clearance in potential kidney donors.
Schück, O., Teplan, V., Malý, J., Franeková, J., Malínská, H., Štollová, M., Látová, I., Urbanová, J., Skibová, J., Viklický, O. Clinical nephrology. 2014, 82(6), 353-357.

Nephrostomy in early posttransplantation period in patients with nonfunctional graft and nondilated collecting system.
Peregrin, J., Hanzal, V., Bürgelová, M., Viklický, O. Cardiovascular and Interventional Radiology. 2014, 37(2), 458-462.

CD14+CD16+and CD14+CD163+monocyte subpopulations in kidney allograft transplantation.
Sekerková, A., Krepsová, E., Brabcová, E., Slatinská, J., Viklický, O., Lánská, V., Stříž, I. BMC Immunology. 2014, 15(4), 1-10.

European renal best practice guideline on the management and evaluation of the kidney donor and recipient.
Pascual, J., Abramowicz, D., Cochat, P., Claas, F., Dudley, C., Harden, P., Heeman, U., Hourmant, M., Maggiore, U., Salvadori, M., Spasovski, G., Squifflet, J., Steiger, J., Torres, A., Vanholder, R., Van Biesen, W., Viklický, O., Zeier, M., Nagler, E. Nefrologia. 2014, 34(3), 293-301.


2013

Molecular profiling of acute and chronic rejections of renal allografts.
Hribova P, Honsova E, Brabcova I, Hruba P, Viklicky O.
Clinical & Developmental Immunology. 2013, 2013(2013), art. ID 509259.

B-cell-related biomarkers of tolerance are up-regulated in rejection-free kidney transplant recipients.
Viklicky O, Krepsova E, Brabcova I, Sekerkova A, Wohlfahrt P, Hribova P, Wohlfahrtova M, Sawitzki B, Slatinska J, Striz I, Volk H, Reinke P.
Transplantation. 2013, 95(1), 148-154.

Molecular markers of rejection and tolerance: lessons from clinical research.
Viklicky O, Hribova P, Brabcova I.
Nephrology Dialysis Transplantation. 2013, 28(11), 2701-2708.

Long-term follow-up of stable kidney transplant recipients after conversion from tacrolimus twice daily immediate release to tacrolimus once-daily prolonged release: A large single-center experience.
 
Slatinska J, Rohal T, Wohlfahrtova M, Viklicky O.
 Transplantation Proceedings. 2013, 45(4), 1491-1496.

The role of belatacept in transplantation: results and implications of clinical trials in the context of other new  biological immunosuppressant agents.
Heemann U, Viklicky O.
Clinical transplantation. 2013, 27(1), E3-E11.

Further evidence of the benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis  B virus infection.
Sperl J, Frankova S, Spicak J, Viklicky O.
Journal of Hepatology. 2013, 58(4), 833-835.

Identification of expanded-criteria donor kidney grafts at lower risk of delayed graft function.
Balaz P, Rokosny S, Wohlfahrtova M, Wohlfahrt P, Bartonova A, Pokorna E, Honsova E, Viklicky O.
Transplantation. 2013, 96(7), 633-638.

Use of phosphate-binding agents is associated with a lower risk of mortality.
Cannata-Andia J, Fernandez-Martin J, Locatelli F, London G, London J, Floege J, Ketteler M, Ferreira A, Covic A, Rutkowski B, Memmos D, Bos W, Teplan V.
Kidney International. 2013, 84(5), 998-1008.

Dual kidney transplant: A single-center experience and review of the literature.
Balaz P, Rokosny S, Wohlfahrt P, Wohlfahrtova M, Adamec M, Janousek L, Fronek J, Viklicky O, Pokorna E
Experimental and clinical Transplantation. 2013, 11(5), 388-395.

Mechanisms and rescue strategies of calcineurin inhibitor mediated tolerance abrogation induced by anti-CD4 mAb treatment.
Siepert A, Broesel S, Vogt K, Ahrlich S, Schmitt-Knosalla I, Loddenkemper C, Kuehl A, Baumgrass R, Gerstmayer B, Tomiuk S, Tiedge M, Viklicky O, Brabcova I, Nizze H, Lehmann M, Volk H, Sawitzki B.
American journal of transplantation. 2013, 13(9), 2308-2321.

Cosmos: the dialysis scenario of CKD-MBD in Europe.
Fernandez-Martin J, Carrero J, Benedik M, Bos W, Covic A, Ferreira A, Floege J, Goldsmith D, Gorriz J, Ketteler M, Kramar R, Locatelli F, London G, Martin P, Memmos D, Nagy J, Naves-Diaz M, Pavlovic D, Rodriguez-Garcia M, Rutkowski B, Teplan V, Tielemans C, Verbeelen D, Wuethrich R, Martinez-Camblor P, Cabezas-Rodriguez J, Sanchez-Alvarez J, Cannata-Andia J.
Nephrology Dialysis Transplantation. 2013, 28(7), 1922-1935.

Sotrastaurin in calcineurin inhibitor-free regimen using everolimus in de novo kidney transplant recipients.
Tedesco-Silva H, Kho M, Hartmann A, Vitko S, Russ G, Rostaing L, Budde K, Campistol J, Eris J, Krishnan I, Gopalakrishnan U, Klupp J.
American journal of transplantation. 2013, 13(7), 1757-1768.

Do ketoanalogues still have a role in delaying dialysis initiation in CKD predialysis patients?.
Aparicio M, Bellizzi V, Chauveau P, Cupisti A, Ecder T, Fouque D, Garneata L, Lin S, Mitch W, Teplan V, Yu X, Zakar G. Seminars in dialysis. 2013, 26(6), 714-719.

Influence of body mass index on the association of weight changes with mortality in hemodialysis patients.
Cabezas-Rodriguez I, Carrero JJ, Zoccali C, Qureshi Ar, Ketteler M, Floege J, London G, Locatelli F, Gorriz JL, Rutkowski B, Memmos D, Ferreira A, Covic A, Teplan V, Bos W, Kramar R, Pavlovic D, Goldsmith D, Nagy J, Benedik M, Verbeelen D, Tielemans C, Wuethrich RP, Martin P, Martinez-Salgado C, Fernandez-Martin JL, Cannata-Andia JB.
Clinical journal of the American Society of Nephrology. 2013, 8(10), 1725-1733.


2012

Long-Term Outcomes of Pre-emptive Valganciclovir Compared with Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation. 
Reischig, T., Hřibová, P., Jindra, P., Hes, O., Bouda, M., Treska, V., Viklický, O. Journal of the American Society of Nephrology. 2012, 23(9), 1588-1597.

Three-year outcomes from BENEFIT-EXT: A phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys.
Pestana, Jom., Grinyo, Jm., Vanrenterghem, Y., Becker, T., Campistol, Jm., Florman, S., Garcia, Vd., Kamar, N., Lang, P., Manfro, Rc., Massari, P., Rial, Mdc., Schnitzler, Ma., Vítko, Š., Duan, T., Block, A., Harler, Mb., Durrbach, A. American journal of transplantation. 2012, 12(3), 630-639.

Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation.
Langer, Rm., Hene, R., Vítko, Š., Christiaans, M., Tedesco-Silva, H., Ciechanowski, K., Cassuto, E., Rostaing, L., Vilatoba, M., Machein, U., Ulbricht, B., Junge, G., Dong, G., Pascual, J. Transplant international. 2012, 25(5), 592-602.

Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.
Kryštůfková, E., Sekerková, A., Stříž, I., Brabcová, I., Girmanová, E., Viklický, O. Nephrology Dialysis Transplantation. 2012, 27(6), 2576-2582.

The FTO gene polymorphism is associated with end-stage renal disease: two large independent case-control studies in general population.
Hubáček, J., Viklický, O., Dlouhá, D., Bloudíčková, S., Kubinova, R., Peasey, A., Pikhart, H., Adámková, V., Brabcová, I., Pokorná, E., Bobak, M. Nephrology Dialysis Transplantation. 2012, 27(3), 1030-1035.

Cytokine gene expression profile in monocytic cells after a co-culture with epithelial cells.
Kolesár, L., Brabcová, E., Thorburn, E., Sekerková, A., Brabcová, I., Jarešová, M., Viklický, O., Stříž, I. Immunologic Research. 2012, 52(3), 269-275.

Tacrolimus-Based, Steroid-Free Regimens in Renal Transplantation: 3-Year Follow-Up of the ATLAS Trial.
Kraemer, , Klinger, , Vítko, S , Glyda, , Midtvedt, , Stefoni, , Citterio, , Pietruck, , Squifflet, , Segoloni, , Krueger, , Sperschneider, , Banas, , Backman, , Weber, , Carmellini, , Perner, , Claesson, , Marcinkowski, , Ostrowski, , Senatorski, , Nordstrom, , Salmela. Transplantation. 2012, 94(5), 492-498.

Effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal.
Basu, A., Liu, T., Banerjee, P., Flynn, E., Zurakowski, D., Datta, D., Viklický, O., Gasser, M., Waaga-Gasser, A., Yang, J., Pal, S. Cancer letters. 2012, 321(2), 179-186.

Keto Acid Therapy in Predialysis Chronic Kidney Disease Patients: Final Consensus.
Aparicio,, M., Bellizzi, V., Chauveau, P., Cupisti, A., Ecder, T., Fouque, D., Garneata, L., Lin, S., Mitch, W., Teplan, V., Zakar, G., Yu, Yx. Journal of renal nutrition. 2012, 22(2, suppl.), S22-S24.

Protein-restricted diets plus keto/amino acids - a valid therapeutic approach for chronic kidney disease patients.
Aparicio,, M., Bellizzi, V., Chauveau, P., Cupisti, A., Ecder, T., Fouque, D., Garneata, L., Lin, S., Mitch, W., Teplan, V., Zakar, G., Yu, Yx. Journal of renal nutrition. 2012, 22(2, suppl.), S1-S21.

Muscle and fat metabolism in obesity after kidney transplantation: No effect of peritoneal dialysis or hemodialysis.
Teplan, V., Malý, J., Gürlich, R., Teplan, V. Jr., Kudla, M., Piťha, J., Racek, J., Haluzík, M., Šenolt, L., Štollová, M. Journal of renal nutrition. 2012, 22(1), 166-170.

Differential Regulation of the Nuclear Factor-kB Pathway by Rabbit Antithymocyte Globulins in Kidney Transplantation.
Urbanová, M., Brabcová, I., Girmanová, E., Zelezny, F., Viklický, O. Transplantation. 2012, 93(6), 589-596.

Time course of peritoneal function in automated and continuous peritoneal dialysis.
 
Michels, W., Verduijn, M., Paříková, A., Boeschoten, E., Struijk, D., Dekker, F., Krediet, R.
 Peritoneal dialysis international. 2012, 32(6), 605-611.

COSMOS: the dialysis scenario of CKD-MBD in Europe.
Fernández-Martín JL, Carrero JJ, Benedik M, Bos WJ, Covic A, Ferreira A, Floege J, Goldsmith D, Gorriz JL, Ketteler M, Kramar R, Locatelli F, London G, Martin PY, Memmos D, Nagy J, Naves-Díaz M, Pavlovic D, Rodríguez-García M, Rutkowski B, Teplan V, Tielemans C, Verbeelen D, Wüthrich RP, Martínez-Camblor P, Cabezas-Rodriguez I, Sánchez-Alvarez JE, Cannata-Andia JB. Nephrol Dial Transplant. 2012, doi: 10.1093/ndt/gfs418.

Keto/Amino Acids Use After Renal Transplantation.
Teplan V. J Ren Nutr. 2012 Mar;22(2 Suppl):S15-6.


2011

A prospective longitudinal study of BK virus infection in 120 Czech renal transplant recipients.
Girmanová, E., Brabcová, I., Bandúr, Š., Hřibová, P., Skibová, J., Viklický, O. Journal of medical virology. 2011, 83(8), 1395-1400.

Molecular phenotypes of kidney graft rejection.
Hřibová, P., Viklický, O. Kidney and Blood Pressure Research. 2011, 34(4), 291-298.

Everolimus and long-term outcomes in renal transplantation.
Campistol, Jm., Fijter De, Jw., Nashan, B., Holdaas, H., Vítko, Š., Legendre, Ch. Transplantation. 2011, 92(3S), "S3"-"S26".

Haplotypic arrangement in CYP3A locus is associated with side effects of proliferative signal inhibitors in renal transplant recipients.
Bandúr, Š., Petrášek, J., Hřibová, P., Novotná, E., Brabcová, I., Viklický, O. Transplantation. 2011, 91(1), "e1"-"e2".

Association of advanced vasculopathy and transforming growth factor-beta1 gene expression with immunoglobulin A nephropathy progression.
Brabcová, I., Tesař, V., Honsová, E., Lodererová, A., Novotná, E., Maixnerová, D., Merta, M., Bürgelová, M., Hřibová, P., Skibová, J., Zadražil, J., Malý, J., Viklický, O. Nephrology Dialysis Transplantation. 2011, 26(2), 573-579.

Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft.
Pavlová, Y., Viklický, O., Slatinská, J., Bürgelová, M., Süsal, C., Skibová, J., Honsová, E., Stříž, I., Kolesár, L., Slavčev, A. Transplant Immunology. 2011, 25(1), 72-76.

Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetes.
Rostaing, L., Neumayer, Hh., Reyes-Acevedo, R., Bresnahan, B., Florman, S., Vítko, Š., Heifets, M., Xing, J., Thomas, D., Vincenti, F. Clinical journal of the American Society of Nephrology. 2011, 6(11), 2696-2704.

In vivo 31P MR spectroscopy of human kidney grafts using the 2D-chemical shift imaging method.
Vyhnanovská, P., Dezortová, M., Herynek, V., Táborský, P., Viklický, O., Hájek, M. Transplantation Proceedings. 2011, 43(5), 1570-1575.


2010

Gender-related determinants of advanced subclinical atherosclerosis in patients undergoing kidney transplantation.
Piťha, J., Teplan, V., Kalousová, M., Racek, J., Štollová, M., Marečková, O., Lánská, V. Kidney and Blood Pressure Research. 2010, 33(3), 227-234.

Acute rejection in low-toxicity regimens: clinical impact and risk factors in the Symphony study.
Frei, U., Daloze, P., Vítko, Š., Klempnauer, J., Reyes-Acevedo, R., Titiz, I., Fricke, L., Bernasconi, C., Eckberg, H. Clinical transplantation. 2010, 24(4), 500-509.

Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results.
Kramer, Bk., Klinger, M., Wlodarczyk, Z., Ostrowski, M., Midvedt, K., Stefoni, S., Citterio, F., Pietruck, F., Squifflet, Jp., Segoloni, G., Kruger, B., Sperschneider, H., Banas, B., Backman, L., Weber, M., Carmellini, M., Perner, F., Claesson, K., Marcinkowski, W., Vítko, Š., Senatorski, G., Salmela, K., Nordstrom, J. Clinical transplantation. 2010, 24(1), "E1"-"E9".

Potential predictive markers in protocol biopsies for premature renal graft loss.
Matl, I., Hřibová, P., Honsová, E., Brabcová, I., Viklický, O. Kidney and Blood Pressure Research. 2010, 33(1), 7-14.

Primary liver transplantation for autoimmune hepatitis: A comparative analysis of the European liver transplant registry.
Schramm, Ch., Bubenheim, M., Adam, R., Karam, V., Buckels, J., O'grady, Jg., Jamieson, N., Pollard, S., Neuhaus, P., Manns, Mm., Porte, R., Castaing, D., Paul, A., Traynor, O., Garden, J., Friman, S., Ericzon, Bo-G., Fischer, L., Vítko, Š., Krawczyk, M., Metselaar, Hj., Foss, A., Kilic, M., Rolles, K., Burra, P., Rogiers, X., Lohse, Aw. Liver transplantation. 2010, 16(4), 461-469.

Molecular phenotypes of acute rejection predict kidney graft prognosis.
Viklický, O., Hřibová, P., Volk, H., Slatinská, J., Petrášek, J., Bandúr, Š., Honsová, E., Reinke, P. Journal of the American Society of Nephrology. 2010, 21(1), 173-180.

Interchangeability of ciclosporin formulations in stable adult renal transplant recipients: comparison of Equoral and Neoral capsules in an international, multicenter, randomized, open-label trial.
Vítko, Š., Ferkl, M. Kidney International. 2010, 77(suppl. 115), "S12"-"S16".



© Institut klinické a experimentální medicíny 2015 - 2016. Všechna práva vyhrazena.

Created by ARSY line

Pro zaměstnance

Intranet
Pošta
Strava
Varování

Zavřít

Tyto internetové stránky používají soubory cookie Více informací zde.

Souhlasím